Last updated on July 2019

Evaluation of TTP399 in Patients With Type 1 Diabetes


Brief description of study

The purpose of this study is to evaluate the safety and efficacy of TTP399 in Type 1 diabetics. This study will be in 2 phases: phase 1 will evaluate the safety of different TTP399 dosage regimens over 1 week of daily dosing. Phase 2 will evaluate the safety and efficacy of a TTP399 dosing regimen over 12 weeks of daily dosing.

Clinical Study Identifier: NCT03335371

Find a site near you

Start Over

Site 01

Chapel Hill, NC United States
  Connect »

Site 05

Escondido, CA United States
  Connect »

Site 13

Aurora, CO United States
  Connect »

Site 06

Atlanta, GA United States
  Connect »

Site 10

West Des Moines, IA United States
  Connect »

Site 16

Asheville, NC United States
  Connect »

Site 03

Durham, NC United States
  Connect »

Site 04

Morehead City, NC United States
  Connect »

Site 12

Wilmington, NC United States
  Connect »

Site 02

Winston-Salem, NC United States
  Connect »

Site 11

Norman, OK United States
  Connect »

Site 07

Greer, SC United States
  Connect »

Site 08

Dallas, TX United States
  Connect »

Site 14

Seattle, WA United States
  Connect »

AMCR Institute

Escondido, CA United States
  Connect »

Atlanta Diabetes Associate

Atlanta, GA United States
  Connect »

Rocky Mountain Diabetes Center

Idaho Falls, ID United States
  Connect »

Iowa Diabetes Research

West Des Moines, IA United States
  Connect »

UNC Diabetes Care Center

Chapel Hill, NC United States
  Connect »

Diabetes & Endocrinology Consultants

Morehead City, NC United States
  Connect »

PMG Research of Wilmington

Wilmington, NC United States
  Connect »

Wake Forest

Winston-Salem, NC United States
  Connect »

Intend Research

Norman, OK United States
  Connect »

USC Westside Center for Diabetes

Beverly Hills, CA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.